Neoplasms benign, malignant and unspecified (incl cysts and polyps) – page 127

Study on Luspatercept and Epoetin Alfa for Patients with Low-Risk Myelodysplastic Syndrome Without Ring Sideroblasts Who Did Not Respond to ESA

Study on the Use of 18F-PSMA-1007 PET/MRI for Diagnosing Significant Prostate Cancer in Patients with Suspected Prostate Cancer

Study on the Use of 18F-PSMA-1007 PET/MRI for Diagnosing Significant Prostate Cancer in Patients with Suspected Prostate Cancer

Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

Study on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation

Study on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation

Study on HPV Vaccine After Treatment for High-Grade Cervical Lesions in Women Over 45

Study on HPV Vaccine After Treatment for High-Grade Cervical Lesions in Women Over 45

Study on the Safety of Tremelimumab Injections for Early-Stage Non-Small Cell Lung Cancer Patients

Study on the Safety of Tremelimumab Injections for Early-Stage Non-Small Cell Lung Cancer Patients

Study on Gemcitabine for Patients with Recurrent Glioblastoma

Study on Gemcitabine for Patients with Recurrent Glioblastoma

Study on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors

Study on Tasquinimod for Patients with Myelofibrosis Who Are Refractory or Intolerant to JAK2 Inhibitors

Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Study of Pembrolizumab for Patients with Classic or Endemic Kaposi's Sarcoma

Study of Pembrolizumab for Patients with Classic or Endemic Kaposi's Sarcoma

Study of SAR445877 and Cetuximab for Adults with Advanced Solid Tumors

Study of SAR445877 and Cetuximab for Adults with Advanced Solid Tumors